Does angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect on the blood-forming bone marrow?

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

VAŠKŮ Anna SOUČEK Miroslav ZNOJIL Vladimír ŘIHÁČEK Ivan CÍDL Karel STŘELCOVÁ Lenka VÁCHA Jiří

Year of publication 1998
Type Article in Periodical
Magazine / Source Experimental Hematology
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords ACEI; RBC
Description One year ACE inhibitor therapy in 11 patients with essential hypertension was found to cause a decrease in red blood cell counts , together with an increased corpuscular volume in these erythrocytes. Thus, IACE therapy could influence local RAS system in blood-forming bone marrow.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.